These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10188788)
1. Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease. Sedman AJ; Bockbrader H; Schwarz RD Life Sci; 1995; 56(11-12):877-82. PubMed ID: 10188788 [TBL] [Abstract][Full Text] [Related]
2. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. Schwarz RD; Callahan MJ; Coughenour LL; Dickerson MR; Kinsora JJ; Lipinski WJ; Raby CA; Spencer CJ; Tecle H J Pharmacol Exp Ther; 1999 Nov; 291(2):812-22. PubMed ID: 10525104 [TBL] [Abstract][Full Text] [Related]
3. Regional brain distribution and binding of the muscarinic receptor agonist CI-979 studied by positron emission tomography in the monkey. Hartvig P; Torstenson R; Bjurling P; Fasth KJ; Längström B; Nordberg A Dement Geriatr Cogn Disord; 1997; 8(5):259-66. PubMed ID: 9298626 [TBL] [Abstract][Full Text] [Related]
4. Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease. Adamus WS; Leonard JP; Tröger W Life Sci; 1995; 56(11-12):883-90. PubMed ID: 10188789 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832. Jaen J; Barrett S; Brann M; Callahan M; Davis R; Doyle P; Eubanks D; Lauffer D; Lauffer L; Lipinski W Life Sci; 1995; 56(11-12):845-52. PubMed ID: 10188784 [TBL] [Abstract][Full Text] [Related]
6. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699 [TBL] [Abstract][Full Text] [Related]
7. The utility of muscarinic agonists in the treatment of Alzheimer's disease. Messer WS J Mol Neurosci; 2002; 19(1-2):187-93. PubMed ID: 12212779 [TBL] [Abstract][Full Text] [Related]
8. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Hartvig P; Nordberg A; Torstenson R; Sjöberg P; Fasth KJ; Långström B Dement Geriatr Cogn Disord; 2002; 13(4):199-204. PubMed ID: 12006729 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979). M'Harzi M; Palou AM; Oberlander C; Barzaghi F Pharmacol Biochem Behav; 1995 May; 51(1):119-24. PubMed ID: 7617721 [TBL] [Abstract][Full Text] [Related]